1. Home
  2. NUWE vs LIXT Comparison

NUWE vs LIXT Comparison

Compare NUWE & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUWE
  • LIXT
  • Stock Information
  • Founded
  • NUWE 1999
  • LIXT 2005
  • Country
  • NUWE United States
  • LIXT United States
  • Employees
  • NUWE N/A
  • LIXT N/A
  • Industry
  • NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • LIXT Biotechnology: Pharmaceutical Preparations
  • Sector
  • NUWE Health Care
  • LIXT Health Care
  • Exchange
  • NUWE Nasdaq
  • LIXT Nasdaq
  • Market Cap
  • NUWE 5.2M
  • LIXT 6.3M
  • IPO Year
  • NUWE N/A
  • LIXT N/A
  • Fundamental
  • Price
  • NUWE $1.30
  • LIXT $1.27
  • Analyst Decision
  • NUWE Strong Buy
  • LIXT
  • Analyst Count
  • NUWE 1
  • LIXT 0
  • Target Price
  • NUWE $17.00
  • LIXT N/A
  • AVG Volume (30 Days)
  • NUWE 1.1M
  • LIXT 155.3K
  • Earning Date
  • NUWE 03-11-2025
  • LIXT 03-18-2025
  • Dividend Yield
  • NUWE N/A
  • LIXT N/A
  • EPS Growth
  • NUWE N/A
  • LIXT N/A
  • EPS
  • NUWE N/A
  • LIXT N/A
  • Revenue
  • NUWE $8,969,000.00
  • LIXT N/A
  • Revenue This Year
  • NUWE $2.18
  • LIXT N/A
  • Revenue Next Year
  • NUWE $25.75
  • LIXT N/A
  • P/E Ratio
  • NUWE N/A
  • LIXT N/A
  • Revenue Growth
  • NUWE 3.66
  • LIXT N/A
  • 52 Week Low
  • NUWE $0.92
  • LIXT $1.25
  • 52 Week High
  • NUWE $26.95
  • LIXT $4.40
  • Technical
  • Relative Strength Index (RSI)
  • NUWE 52.78
  • LIXT 28.82
  • Support Level
  • NUWE $1.17
  • LIXT $1.35
  • Resistance Level
  • NUWE $1.48
  • LIXT $3.00
  • Average True Range (ATR)
  • NUWE 0.09
  • LIXT 0.26
  • MACD
  • NUWE 0.01
  • LIXT -0.13
  • Stochastic Oscillator
  • NUWE 45.45
  • LIXT 1.15

About NUWE Nuwellis Inc.

Nuwellis Inc is a medical device company. Its solutions includes Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Share on Social Networks: